[Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
D000152:Acne Vulgaris / Q000188:drug therapy*; D000328:Adult; D002986:Clinical Trials as Topic; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use*; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D003534:Cyproterone
Ostrogenreduzierter Ovulationshemmer zur Aknetherapie. Doppelblindstudie zum Vergleich von Diane-35 gegen Diane.